Menu
Amrit Mahotsav Logo
International Year of Cooperatives Logo

Important Document

Important Document

Sr. No. Title Details
151 Seeking comments/views/ suggestions from Stakeholders on Framing of Recruitment Rules for the post of Staff Car Driver in Department of Pharmaceuticals - reg
152 Guidelines on Pharmaceutical Innovation & Entrepreneurship
153 FAQs on the Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme 'Strengthening of Pharmaceuticals Industry' (SPI)
154 Extension of timeline to submit proposal: Invitation of Tender for selection of Public Financial Institution (Government Company) for providing services of Project Management Consultant (PMC) for the Scheme Strengthening of Pharmaceuticals Industry (SPI)
155 Approval accorded to the States under the scheme 'Promotion of Medical Devices Park'
156 Awards to the leading Pharma and Medical Devices Industry playersIndia Pharma 2022 & India Medical Devices 2022-Extension of Date for invitation of Applications -reg
157 Annual Report 2021-22
158 Invitation of Applications for the posts of Director of NIPER- Ahmedabad and NIPER-Raebareli
159 Invitation of Applications under the PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) - extension till 30.04.2022
160 Notice: PPDS scheme for FY 21-22 - Selection of agencies for conducting studies (Long Term and Short Term) - reg.
161 Portal for India Pharma and India Medical Device Awards
162 Timeline Extension for filling applications under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials(KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) upto 31.03.2022
163 Guidelines for the Scheme for Strengthening of Pharmaceuticals Industry (SPI)
164 Guidelines regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022.
165 Notice regarding Awards to the leading Pharma and Medical Devices Industry players - India Pharma 2022 & India Medical Devices 2022
166 Public Notice dated 28.02.2022 :Inviting details of local manufacturers of specific Drugs -reg.
167 List of approved applicants under PLI Scheme for Bulk Drug (Dated :20-01-2021)
168 Public Notice dated 01.02.2022: Relaxation on Global Tender Enquiry (GTE) under Rule 161(iv) of General Financial Rules (GFRs) 2017 for procurement of Medical Devices - reg.
169 Hiring of Technical Consultant for Pharmaceuticals and Medical Devices.
170 Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/Drug Intermediates and Active Pharmaceuticals Ingredients (APIs) in the Country
171 List of approved applicants under PLI Scheme for Medical Devices
172 Press Notes regarding Approvals accorded under PLI Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the country. Dated: 9th December, 2021
173 Press Notes regarding Approval accorded under PLI Scheme for Promotion of Domestic Manufacturing of Medical Devices. Dated: 9th December, 2021
174 List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Pharmaceuticals
175 List of Approved Applicants under the the Production Linked Incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)/ Active Pharmaceutical Ingredients (APIs) in India
176 Inviting details of local manufacturers of specific medical devices/equipments
177 Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
178 Press Release regarding Selection of applicants under the Production Linked Incentive (PLI) scheme for Pharmaceuticals
179 Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
180 FAQ: Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof
181 Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
182 Corrigendum- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof -regarding.
183 Corrigendum: R.F.P. for Short Term Study and Long Term Study -Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
184 Regarding- Draft Policy to Catalyze Research & Development and Innovation in the Pharma - MedTech Sector in India
185 Circulation of Draft Policy to Catalyze Research & Development and Innovation in the Pharma- MedTech Sector in India
186 R.F.P. for Long Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
187 R.F.P. for Short Term Study- Invitation of Tender for selection of reputed empanelled agencies with Government of India for conducting studies and submission of report thereof.
188 Filling up the post of Managing Director, Bengal Chemicals & Pharmaceuticals Limited (BCPL) on deputation basis through Search-cum-Selection Committee (SCSC).
189 Corrigendum under PLI scheme for Pharmaceuticals
190 Filling up the post of Chief Executive Officer (CEO) in the Pharmaceutical and Medical Devices Bureau of India (PMBI), a Society under the aegis of Department of Pharmaceuticals, Government of India on deputation including short term contract.
191 Invitation of Applications for Ofloxacin under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in India.
192 Notice for Time Extension of PLI for Bulk Drug and PLI for Medical Devices
193 Notification regarding the revision of ceiling prices under para 18(i) of the Drugs (Prices Control) Order, 2013.
194 Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals
195 Engagement of 04 Consultant(Non-tech, SO level) in the Department of Pharmaceuticals- reg
196 Revised Notice- Invitation of Applications under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of Critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country
197 Corrigendum- Operational Guidelines of PLI scheme for Pharmaceuticals
198 Annual Report 2020-21
199 Observing the 7th International Yoga Day, 2021.
200 Revised Notice- Invitation of Applications Under the Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country

Pages